deltatrials
Unknown PHASE4 NCT01227226

Tear Osmolarity Over Time With Artificial Tears

Sponsor: Allergan

Conditions Dry Eye
Interventions Artificial tears
Updated 6 times since 2017 Last updated: Feb 4, 2011 Started: Oct 31, 2010 Primary completion: Mar 31, 2011 Completion: Mar 31, 2011

A PHASE4 clinical study on Dry Eye, this trial is ongoing. The trial is conducted by Allergan and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Enrolling By Invitation PHASE4

    First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Allergan
  • Hom, Milton M., OD, FAAO
Data source: Hom, Milton M., OD, FAAO

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Azusa, United States